Centogene NV
F:39K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Centogene NV
F:39K
|
DE |
|
AM Resources Corp
F:76A
|
CA |
|
Daiwa Securities Group Inc
F:DSE
|
JP |
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
|
Musashi Seimitsu Industry Co Ltd
F:67X
|
JP |
|
Stampede Drilling Inc
OTC:STPDF
|
CA |
|
Novo Resources Corp
F:1NO
|
CA |
|
P
|
Petra Diamonds Ltd
XMUN:FPO
|
UK |
|
L
|
Lincoln Gold Mining Inc
XMUN:ZMG
|
CA |
|
R
|
Ross Group PLC
OTC:ROSSF
|
UK |
|
D
|
discoverIE Group plc
F:9A5
|
UK |
|
S
|
Singapore Exchange Ltd
XBER:SOU
|
SG |
|
V
|
Viavi Solutions Inc
F:UNS1
|
US |
Bankruptcy Probability
Centogene NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Centogene NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Centogene NV
NASDAQ:CNTG
|
1.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
468.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Centogene NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Centogene NV has total debt of 52.3m EUR. This includes both short-term (0 EUR) and long-term (52.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
